Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular LymphomaDaniela Drandi, Marco Ladetto, Manuela Gambella et al.|Journal of Molecular Diagnostics|2015Cited by 132
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphomaSimone Ferrero, Marco Ladetto, Angela Gueli et al.|Annals of Hematology|2013Cited by 20
A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III TrialGian Maria Zaccaria, Marco Ladetto, Umberto Vitolo et al.|Cancers|2021Cited by 13
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: Evidence for premature aging of the myeloid compartmentChiara Lobetti‐Bodoni, Marco Ladetto, Elisa Bernocco et al.|Mechanisms of Ageing and Development|2012Cited by 9
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow‐upPaola Ghione, Simone Ferrero, Paola Omedè et al.|British Journal of Haematology|2017Cited by 1